Summary of patient characteristics and treatment
| Case No. | Sex | Age | Lesion Location | Comorbidities | Mori Lesion Type | Stenosis (%) | Predilatation (mm) | Stent (mm) | Complication | |
|---|---|---|---|---|---|---|---|---|---|---|
| Before | After | |||||||||
| 1 | F | 58 | BA | H | B | 59 | 0 | Maxxum 2.75/12 | S660 2.75/18 | Acute in-stent thrombosis* |
| 2 | F | 63 | BA | H, D, L | A | 65 | 5 | Jo flex 4/16 | ||
| IVA, Lt | C | 60 | 0 | S670 3/24 | ||||||
| 3 | F | 65 | IVA, Lt | H | B | 62 | 10 | S670 3.5/18 | ||
| 4 | M | 60 | BA | H | C | 82 | 0 | Maverick 2/12 | Cypher 2.5/13 | Dizziness, ataxia† |
| 5 | M | 51 | IVA, Rt | H, D, S | C | 95 | 0 | Maestro 1.5/20 | Jo flex 2.5/23 | |
| 6 | M | 70 | IVA, Lt | H, D, S, C | A | 90 | 0 | S670 4/18 | ||
| 7 | F | 66 | IVA, Lt | H, D | B | 70 | 0 | Jo flex 4/23 | ||
| 8 | M | 55 | IVA, Lt | H, D, L, S, C | A | 95 | 0 | S660 2.5/9, 2.5/12‡ | ||
| 9 | M | 70 | IVA, Rt | H, C | C | 70 | 0 | Jo bare 5/17 | ||
| 10 | M | 74 | IVA, Rt | H, D, S, M | B | 69 | 0 | Ranger 2.5/20 | AVE 3.5/12 | |
| 11 | F | 60 | BA | H | C | 95 | 0 | S670 3/18 | ||
| 12 | M | 69 | BA | H | B | 90 | 0 | Jo flex 3.5/16 | ||
| 13 | M | 62 | IVA, Lt | H, L | B | 74 | 0 | Larus 2.5/10 | Jo Stent 3.0/12 | |
| 14 | F | 65 | BA | H | C | 90 | 5 | S670 3.5/24 | ||
| IVA, Lt | B | 60 | 0 | S670 4/24 | ||||||
| 15 | F | 76 | IVA, Lt | H, D, L, S | C | 80 | 0 | S660 2.5/15,S670 3/19§ | ||
| 16 | M | 68 | IVA, Lt | H, S, C | C | 50 | 5 | S7 4/30 | ||
| 17 | M | 60 | IVA, Lt | H, L, S | C | 90 | 0 | Maestro 1.5/20 | Jo flex 3/19 | |
Note.—IVA indicates intracranial vertebral artery; BA, basilar artery; H, hypertension; D, diabetes mellitus; L, hyperlipidemia; S, smoking; C, coronary artery disease.
* Recanalized after intraarterial abciximab injection.
† Improved during hospitalization.
‡ First stent was trapped by the tight stenosis and had to be deployed proximal to the lesion site; thus, a second stent was used for distal angioplasty.
§ Two stents used for long length of the lesion.